openPR Logo
Press release

Global Thalassemia Market Size – Forecast to 2026

Thalassemia Market Size – Forecast to 2026

Thalassemia Market Size – Forecast to 2026

The findings reviewed by GME stated that the Global Thalassemia Market will expand with a CAGR value of 10.2 percent from 2021 to 2026. Several drivers are likely to accelerate the thalassemia market further, including an increasing occurrence of thalassemia, growing public awareness, expanding expenditure in research & development, and the growing need for improved curative gene therapy.

Browse 159 Market Data Tables and 119 Figures spread through 189 Pages and in-depth TOC on “Global Thalassemia Market - Forecast to 2026” https://www.globalmarketestimates.com/market-report/global-thalassemia-market-3138

By Therapeutic Class (Iron Chelating Drugs), By Pipeline (Gene Therapy), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis.
Key Market Insights
• An increasing number of patented medicines and targeted therapies for thalassemia treatment would boost the global thalassemia market.
• Iron chelation prevents iron toxicity complications such as heart and hepatic malfunction which makes it a perfect therapeutic class for thalassemia.
• Gene therapy enables successful exvivo genetic alteration of human stem cells, which can result in hemoglobin synthesis and a significant therapeutic advantage in thalassemia patients.
• The increasing number of thalassemia patients in the U.S is expected to propel the North American market forward.
• Acceleron Pharma, Inc., Bluebird Bio, Inc., CRISPR Therapeutics, La Jolla Pharmaceutical Company, Incyte Corporation, IONIS Pharmaceuticals, GlaxoSmithKline plc., Kiadis Pharma, Lonza Group AG, Alnylam Pharmaceuticals Inc, Sangamo Bioscience, Calimmune Inc, Gamida Cell Ltd, Editas Medicine Inc, Pharma Essentia Corp, Gilead Sciences Inc, Merck & Co Inc, Zydus Cadila Healthcare Ltd, Protagonist Therapeutics Inc, and others, are major players of thalassemia market.

Browse the Report @ https://www.globalmarketestimates.com/market-report/global-thalassemia-market-3138

Therapeutic Class Outlook (Revenue, USD Billion, 2021-2026)
• Iron Chelating Drugs

Pipeline Outlook (Revenue, USD Billion, 2021-2026)
• Gene Therapy

Regional Outlook (Revenue, USD Billion, 2021-2026)
North America
• The U.S.
• Canada
• Mexico
Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Rest of APAC
Central & South America
• Brazil
• Argentina
• Rest of CSA
Middle East & Africa
• Saudi Arabia
• UAE
• Rest of MEA

Contact: Yash Jain
Email address: yash.jain@globalmarketestimates.com
Phone Number: +16026667238
Website: https://www.globalmarketestimates.com/
Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php

B-502, Kemp Plaza, Mindspace, Malad West, Mumbai: 400 064, India

Global Market Estimates is an India based market research and consulting company. The company provides syndicated research reports, customised research reports and consulting services to their clients and helps them achieve their business goals on a commercial level. Global Market Estimates database is used by the world's well known and prolific academic institutions and Fortune 500 companies to understand the global and regional business environment to excel in their business goals.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Thalassemia Market Size – Forecast to 2026 here

News-ID: 2286141 • Views:

More Releases from Global Market Estimates Research & Consultants

Global Market Estimates Hosts Exclusive Webinar on Future Trends in Quick Commerce
Global Market Estimates Hosts Exclusive Webinar on Future Trends in Quick Commer …
Gain Strategic Insights and a Comprehensive Report on August 1st Global Market Estimates (GME) is excited to announce an exclusive webinar, "Future Trends in the Global Quick Commerce Market: Forecasts to 2029," scheduled for August 1, 2024, at 11am EST. This insightful session will feature Mr. Yash Jain, Director - Global Accounts & Strategic Advisory. For a registration fee of USD 499, attendees will receive a comprehensive report valued at USD 5,450,
Global Flare Monitoring Market Size & Trends
Global Flare Monitoring Market Size & Trends
According to a new market research report published by Global Market Estimates, the global flare monitoring market is expected to grow at a CAGR of 6.5% from 2024 to 2029. Global flare monitoring market growth is driven by factors such as safety and risk management and growing emphasis on reduction of emissions. Unlock the Executive Summary of the report at only USD 249. Book a call now: https://tidycal.com/yashsushiljain/unlock-strategic-insights-press-release Key Market Insights • As per
Global Fiber Optic Component System Market Size & Trends
Global Fiber Optic Component System Market Size & Trends
According to a new market research report published by Global Market Estimates, the global fiber optic component system market is expected to grow at a CAGR of 8.46 % from 2024 to 2029. Global fiber optic component system market growth is driven by factors such as growing demand for safety regulations and technological developments. Unlock the Executive Summary of the report at only USD 249. Book a call now: https://tidycal.com/yashsushiljain/unlock-strategic-insights-press-release Key Market
Global Rechargeable Battery Market Size & Trends
Global Rechargeable Battery Market Size & Trends
According to a new market research report published by Global Market Estimates, the global rechargeable battery market is expected to grow at a CAGR of 15.4% from 2024 to 2029. Rechargeable batteries have been growing in popularity due to their inherent superiority over disposable batteries in environmental pollution. As rechargeable batteries can be recharged after every use, they cause much lower environmental degradation as compared to disposable batteries, which are discarded

All 5 Releases


More Releases for Thalassemia

Beta Thalassemia Market Trends, Treatment Landscape, and Growth Opportunities
Introduction Beta thalassemia is a genetic blood disorder caused by mutations in the beta-globin gene, leading to reduced or absent production of the beta-globin chains of hemoglobin. This results in anemia, fatigue, and a range of complications that can be life-threatening if untreated. The severity of beta thalassemia varies from thalassemia minor, which typically requires no treatment, to thalassemia major (Cooley's anemia), which can lead to severe symptoms and require frequent
Thalassemia Market to witness steady growth increase by 2024
Zion Market Research analysts forecast the latest report on "Thalassemia Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016-2024", according to their latest report the Thalassemia Market report covers the overall and all-inclusive analysis of the Thalassemia Market with all its factors that have an impact on market growth. The Thalassemia Market's complete outline is crystal clear penned down in the global Thalassemia Market research report such that
Thalassemia Treatment Market is driven by increase in number of altered thalasse …
Thalassemia Treatment Market - Snapshot The global thalassemia treatment market is driven by increase in number of altered thalassemia genes across the globe. The global market was valued at US$ 842.0 Mn in 2017 and is projected to expand at a CAGR of 7.9% from 2018 to 2026 to reach US$ 1,639.6 Mn by 2026. The global market is witnessing high growth owing to increase in blood transfusion and chelation therapy
Thalassemia - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Thalassemia - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Thalassemia - Pipeline Review, H1 2017, provides an overview of the Thalassemia (Hematological Disorders) pipeline landscape. Thalassemia is a group of inherited blood disorders that affect the body's ability to produce hemoglobin and red blood cells. Symptoms
Global Thalassemia Market Report: 2016 Edition
Thalassemia is a hereditary blood disorder in which a person’s body makes an abnormal form of hemoglobin, which is the protein molecule in red blood cells (RBCs), which carries oxygen. The disorder results in unwarranted damage of red blood cells, which leads to anemia. Anemia is a condition in which the body doesn’t have adequate amount of normal and healthy red blood cells. There are majorly two types of thalassemia
Global Beta Thalassemia Testing Sales Market Report 2017
Summary This report studies sales (consumption) of Beta Thalassemia Testing in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Genorama HiMedia Laboratories DiagCor Bioscience Tosoh Bioscience Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Beta Thalassemia Testing in these